The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 30, 2021

Filed:

Sep. 24, 2019
Applicant:

Janssen Biotech, Inc., Horsham, PA (US);

Inventors:

Jewel Johanns, Devon, PA (US);

Katherine Li, Wallingford, PA (US);

Colleen Marano, Malvern, PA (US);

Richard Strauss, Doylestown, PA (US);

Hongyan Zhang, Malvern, PA (US);

Christopher O'Brien, Lafayette Hill, PA (US);

Omoniyi Adedokun, Phoenixville, PA (US);

Kimberly Shields-Tuttle, West Chester, PA (US);

Assignee:

Janssen Biotech, Inc., Horsham, PA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); C07K 16/24 (2006.01); A61K 9/08 (2006.01); A61K 47/22 (2006.01); A61K 47/26 (2006.01); A61K 47/18 (2017.01); A61P 1/04 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/244 (2013.01); A61K 9/0019 (2013.01); A61K 9/08 (2013.01); A61K 39/00 (2013.01); A61K 47/183 (2013.01); A61K 47/22 (2013.01); A61K 47/26 (2013.01); A61P 1/04 (2018.01); A61K 2039/505 (2013.01); A61K 2039/54 (2013.01); A61K 2039/545 (2013.01); C07K 2317/31 (2013.01); C07K 2317/565 (2013.01);
Abstract

Described are methods and compositions for clinical proven safe and effective treatment of ulcerative colitis, particularly moderately to severely active ulcerative colitis in patients who have had an inadequate response to or are intolerant of a conventional or existing therapy by intravenous and/or subcutaneous administration of an anti-IL-12/IL-23p40 antibody.


Find Patent Forward Citations

Loading…